Disease Area Expert Transplant

CSL's R&D organisation is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.

The incumbent will be accountable for executing on existing and informing new TA strategic directions including identification of promising new targets, pathomechanisms and indications aligned with CSL development capabilities (internal and external). Scientific Leadership and Strategy.

You are responsible for pathomechanism and disease indication reviews to identify new strategic directions and review and refine existing strategies, in particular with respect to:

• new targets / pathways
• new indications
• new patient segments
• Co-develop, in liaison with RTAL, the portfolio strategy for TA relevant disease areas

• Identify and evaluate emerging trends and technologies as well as generate and maintain relevant indication competitive landscapes to identify areas of future unmet need and differentiation opportunities; stay abreast of the industry pipeline in relevant indication segments
• Develop and maintain indication TPPs in collaboration with Clin Development  and Commercial
• Generate new  NPOs in collaboration with the RTAL,  other Core TA team members and functional representatives including the preparation of S0 and SG1 proposals for approval by governance bodies (RSC; REDC)
• Evaluate NPOs sourced by REI/BD and coordinate/co-lead due diligences (incl. wet diligence activities) in collaboration with other Research and R&D functions
• Work with the RTAL and TA RST Modality lead to guide the selection of optimal therapeutic modalities against portfolio targets of interest

• Foster cross-TA collaboration on relevant pathomechanisms
• Liaise with REI and BD on scouting focus and support TA search strategy
• Establish and maintain external partnering and KOL networks in liaison with REI and BD  (e.g. through CSL representation at relevant conferences)
• Identify  and liaise with KOLs to build indication-specific advisory groups, organize and conduct scientific adboards to review and validate strategic directions (incl. indication TPPs)
• Identify and actively manage partnerships with academic institutions, industry experts, and external collaborators.
• Drive SME input to support R&D external due diligence activities.
• Represent the organisation at scientific conferences, industry meetings, and dashboards. PhD and/or MD/MBBS with experience and strong track record in basic science and translational research / medicine 

• Deep pathobiology expertise in relevant pathways and strong understanding of the drug development process with proven track record of translating drug targets and drug candidates into clinical development candidates
• Exceptional leadership and team-building skills with experience to work in a matrix organization and the ability to inspire and motivate a diverse group of professionals
• Strong strategic thinking and problem-solving abilities, with a focus on innovation and continuous improvement.
• Excellent communication and interpersonal skills, with the ability to build effective relationships with internal and external stakeholders
• Proven track record in managing external relationships and extensive scientific and R&D industry network
• Minimum of 12+ years of industry or equivalent experience required

We encourage you to make your well-being a priority. It's important and so are you. Learn more about how we care at CSL.

CSL is a leading global biotechnology company with a dynamic portfolio of life-saving medicines, including those that treat haemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise to save lives through innovation. Learn more about CSL.

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. Learn more Inclusion and Belonging | CSL